19 results
8-K
EX-10.3
PSTX
Poseida Therapeutics Inc
7 Aug 23
Astellas and Poseida Therapeutics Announce Strategic
9:01am
confidential information provided to such Third Party (subject to any limitations for competitively sensitive information in order to comply with antitrust laws
8-K
q8zeobeu7j1wub3
7 Sep 22
Other Events
8:01am
8-K
EX-99.1
99xmhsmmgdu cjwea
11 Aug 22
Poseida Therapeutics Provides Updates and Financial Results for the Second Quarter of 2022
4:27pm
424B5
noh6ucgc
4 Aug 22
Prospectus supplement for primary offering
4:52pm
8-K
gxkxx0
3 Aug 22
Results of Operations and Financial Condition
4:29pm
424B5
6wq0kaeqy1nv2bjlnxk
3 Aug 22
Prospectus supplement for primary offering
4:05pm
8-K
b5jhd9dflncun35
3 Aug 22
Poseida Therapeutics Announces Strategic Global
7:36am
8-K
EX-99.1
h00k8n
3 Aug 22
Poseida Therapeutics Announces Strategic Global
7:36am
DRS
EX-2.1
8bldp193j
17 Apr 20
Draft registration statement
12:00am
S-1
EX-2.2
i6pqz5iefisc
4 Jan 19
IPO registration
3:19pm
DRS
EX-2.2
djxdto5oc569 n0i
1 Nov 18
Draft registration statement
12:00am
- Prev
- 1
- Next